People: Biogen Idec Inc (BIIB.O)

BIIB.O on Nasdaq

339.97USD
22 Aug 2014
Price Change (% chg)

$1.32 (+0.39%)
Prev Close
$338.65
Open
$339.84
Day's High
$341.90
Day's Low
$337.00
Volume
677,368
Avg. Vol
1,144,109
52-wk High
$358.89
52-wk Low
$206.60

Search Stocks

Papadopoulos, Stelios 

Brief Biography

Dr. Stelios B. Papadopoulos, Ph.D., has been appointed as Independent Chairman of the Board of Biogen Idec Inc., with effective June 2014. Dr. Papadopoulos is the Chairman of Exelixis, Inc., a drug discovery and development company that he co-founded in 1994. Previously, he was an investment banker with Cowen & Co., LLC, a financial services company, focusing on the biotechnology and pharmaceutical sectors, from 2000 until his retirement as Vice Chairman in August 2006. Prior to joining Cowen & Co., Dr. Papadopoulos served for 13 years as an investment banker at PaineWebber, Inc., a financial services company, where he was most recently Chairman of PaineWebber Development Corp., a PaineWebber subsidiary focusing on biotechnology. Dr. Papadopoulos is a member of the boards of directors of BG Medicine, Inc. and Regulus Therapeutics, Inc., both life sciences companies. During the past five years, Dr. Papadopoulos has also served as a director of Anadys Pharmaceuticals, Inc., a biopharmaceutical company.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stelios Papadopoulos

--

George Scangos

15,015,100

Paul Clancy

4,486,260

Kenneth Di Pietro

3,254,520

Susan Alexander

2,162,200

John Cox

3,671,600
As Of 30 Dec 2013
Search Stocks